Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yoshiyuki Takahashi"'
Autor:
Kanji Sugita, Takeshi Inukai, Yoshiyuki Takahashi, Atsushi Watanabe, Kenichi Koike, Kumiko Goi, Shinpei Somazu, Hideki Muramatsu, Seiji Kojima, Koshi Akahane, Hiroko Oshiro, Kazuo Sakashita, Yoshiyuki Furuichi, Asahito Hama
Publikováno v:
Pediatric Transplantation. 23
JMML is an aggressive hematopoietic malignancy of early childhood, and allogeneic HSCT is the only curative treatment for this disease. Umbilical cord blood is one of donor sources for HSCT in JMML patients who do not have an HLA-compatible relative,
Autor:
Asahito Hama, Hideki Muramatsu, Atsushi Narita, Eri Nishikawa, Nozomu Kawashima, Nobuhiro Nishio, Seiji Kojima, Yoshiyuki Takahashi
Publikováno v:
Pediatric Transplantation; Nov2020, Vol. 24 Issue 7, p1-6, 6p
Autor:
Xinan Wang, Yinyan Xu, Seiji Kojima, Yuko Sekiya, Yoshinori Ito, Atsushi Narita, Yusuke Okuno, Olfat Ismael, Yuka Torii, Yoshiyuki Takahashi, Shaimaa Elmahdi, Hideki Muramatsu, Asahito Hama, Nozomu Kawashima
Publikováno v:
Pediatric transplantation. 20(1)
We analyzed the correlation between rabbit ATG (rATG) serum levels and clinical outcomes in 37 children who received rATG at a total dose of 10 or 15 mg/kg during HSCT conditioning from an alternative donor. Fourteen patients had advanced malignant d
Autor:
Nobuhiro, Watanabe, Yoshiyuki, Takahashi, Kimikazu, Matsumoto, Yasuo, Horikoshi, Asahito, Hama, Hideki, Muramatsu, Nao, Yoshida, Hiroshi, Yagasaki, Kazuko, Kudo, Keizo, Horibe, Koji, Kato, Seiji, Kojima
Publikováno v:
Pediatric transplantation. 15(6)
Although some studies have reported that TBI and MEL offer an effective conditioning regimen for autologous SCT in acute leukemia, little has been reported regarding outcomes of allogeneic SCT. We retrospectively evaluated outcomes for 50 pediatric p
Autor:
Nao Yoshida, Asahito Hama, Hiroshi Yagasaki, Yasuo Horikoshi, Nobuhiro Watanabe, Koji Kato, Yoshiyuki Takahashi, Hideki Muramatsu, Seiji Kojima, Kimikazu Matsumoto, Keizo Horibe, Kazuko Kudo
Publikováno v:
Pediatric Transplantation.
Watanabe N, Takahashi Y, Matsumoto K, Horikoshi Y, Hama A, Muramatsu H, Yoshida N, Yagasaki H, Kudo K, Horibe K, Kato K, Kojima S. Total body irradiation and melphalan as a conditioning regimen for children with hematological malignancies undergoing
Autor:
Nobuhiro, Nishio, Yoshiyuki, Takahashi, Haruhiko, Ohashi, Sayoko, Doisaki, Hideki, Muramatsu, Asahito, Hama, Akira, Shimada, Hiroshi, Yagasaki, Seiji, Kojima
Publikováno v:
Pediatric transplantation. 15(2)
DC is an inherited bone marrow failure syndrome mainly characterized by nail dystrophy, abnormal skin pigmentation, and oral leukoplakia. Bone marrow failure is the most common cause of death in patients with DC. Because previous results of HSCT with
Autor:
Hideki Muramatsu, Asahito Hama, Sayoko Doisaki, Akira Shimada, Hiroshi Yagasaki, Nobuhiro Nishio, Haruhiko Ohashi, Seiji Kojima, Yoshiyuki Takahashi
Publikováno v:
Pediatric Transplantation.
Nishio N, Takahashi Y, Ohashi H, Doisaki S, Muramatsu H, Hama A, Shimada A, Yagasaki H, Kojima S. Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita. Pediatr Transplant
Autor:
Makito Tanaka, Yoshiyuki Takahashi, Hideki Muramatsu, Asahito Hama, Kazuko Kudo, Seiji Kojima, Hiroshi Yagasaki, Masafumi Ito, Nao Yoshida, Nobuhiro Nishio, Ayami Yoshimi
Publikováno v:
Pediatric transplantation. 13(7)
ES is a complication that occurs immediately before or at the timing of neutrophil engraftment following autologous or allogeneic SCT. It is characterized by fever, skin rash, and non-cardiac pulmonary infiltrates. We evaluated the incidence, risk fa